购物车
- 全部删除
- 您的购物车当前为空
Larotaxel (XRP9881) 是一种紫杉烷类似物,具有抗癌活性,通过促进微管蛋白装配和稳定微管发挥其细胞毒性作用,并通过细胞凋亡诱导细胞死亡。Larotaxel (XRP9881) 是一种可穿过血脑屏障的化合物,对 Docetaxel 的亲和力比 P-糖蛋白 1 高,可用于研究乳腺癌和膀胱癌。
Larotaxel (XRP9881) 是一种紫杉烷类似物,具有抗癌活性,通过促进微管蛋白装配和稳定微管发挥其细胞毒性作用,并通过细胞凋亡诱导细胞死亡。Larotaxel (XRP9881) 是一种可穿过血脑屏障的化合物,对 Docetaxel 的亲和力比 P-糖蛋白 1 高,可用于研究乳腺癌和膀胱癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,090 | 现货 | |
5 mg | ¥ 2,780 | 现货 | |
10 mg | ¥ 3,970 | 现货 | |
25 mg | ¥ 6,390 | 现货 | |
50 mg | ¥ 8,630 | 现货 |
产品描述 | Larotaxel (XRP9881) is a taxane analogue that has anticancer activity, exerts its cytotoxic effects by promoting tubulin assembly and stabilizing microtubules, and ultimately induces cell death through apoptosis. Larotaxel (XRP9881) is a compound that crosses the blood-brain barrier and has a higher affinity for Docetaxel than P-glycoprotein 1, which can be used to study breast and bladder cancer. |
别名 | 拉洛紫杉醇, XRP9881 |
分子量 | 831.9 |
分子式 | C45H53NO14 |
CAS No. | 156294-36-9 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (60.10 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.